Correlation Between Lyra Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Lyra Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Lyra Therapeutics and Terns Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lyra and Terns is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Terns Pharmaceuticals. In addition to that, Lyra Therapeutics is 2.44 times more volatile than Terns Pharmaceuticals. It trades about -0.18 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.24 per unit of volatility. If you would invest 699.00 in Terns Pharmaceuticals on August 24, 2024 and sell it today you would lose (128.00) from holding Terns Pharmaceuticals or give up 18.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Lyra Therapeutics |
| Terns Pharmaceuticals |
Lyra Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Lyra Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Terns Pharmaceuticals vs. Lyra Therapeutics | Terns Pharmaceuticals vs. Hookipa Pharma | Terns Pharmaceuticals vs. Cingulate Warrants | Terns Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |